Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1983;305(5930):150–153. doi: 10.1038/305150a0

Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis

Rihito Watanabe 1, Helmut Wege 1, Volker ter Meulen 1
PMCID: PMC7094959  PMID: 6310411

Abstract

Viruses have been found to induce inflammatory demyelinating lesions in central nervous system (CNS) tissue of both animal and man, either by natural infections or after vaccination1,2. At least two different pathogenic mechanisms have been proposed for these changes, a cytopathic viral infection of oligodendroglia cells with subsequent cell death, and a host immune reaction against virus and brain antigens. We now report the occurrence of cell-mediated immune reactions against basic myelin proteins in the course of coronavirus infections in Lewis rats. Infection of rats with the murine coronavirus JHM leads to demyelinating encephalomyelitis developing several weeks to months post-infection3–7. Lymphocytes from these diseased Lewis rats can be restimulated with basic myelin protein (BMP) and adoptive transfer of these cells leads to lesions resembling those of experimental allergic encephalomyelitis (EAE) in recipients, which can be accompanied by a mild clinical disease. This model demonstrates that a virus infection in CNS tissue is capable of initiating an autoimmune response which may be of pathogenic importance.

References

  • 1.Weiner LP, Johnson RT, Herndon RM. New Engl. J. Med. 1973;288:1103–1110. doi: 10.1056/NEJM197305242882106. [DOI] [PubMed] [Google Scholar]
  • 2.ter Meulen V, Hall WW. J. gen. Virol. 1978;41:1–25. doi: 10.1099/0022-1317-41-1-1. [DOI] [PubMed] [Google Scholar]
  • 3.Nagashima K, Wege H, Meyermann R, ter Meulen V. Acta neuropath. 1978;44:63–70. doi: 10.1007/BF00691641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Nagashima K, Wege H, Meyermann R, ter Meulen V. Acta neuropath. 1979;45:205–213. doi: 10.1007/BF00702672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Sörensen O, Percy D, Dales S. Archs Neurol. 1980;37:478–484. doi: 10.1001/archneur.1980.00500570026003. [DOI] [PubMed] [Google Scholar]
  • 6.Sörensen O, Dugre R, Percy D, Dales S. Infect. Immunity. 1982;37:1248–1260. doi: 10.1128/iai.37.3.1248-1260.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wege H, Koga M, Watanabe R, Nagashima K, ter Meulen V. Infect. Immunity. 1983;39:1316–1324. doi: 10.1128/iai.39.3.1316-1324.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Richert JR, Driscoll BF, Kies MW, Alvord EC. J. Immun. 1979;122:494–496. [PubMed] [Google Scholar]
  • 9.Vandevelde M. Acta neuropath. 1982;56:285–293. doi: 10.1007/BF00691260. [DOI] [PubMed] [Google Scholar]
  • 10.Lipton HL, Dal Canto MC. Science. 1976;192:62–64. doi: 10.1126/science.176726. [DOI] [PubMed] [Google Scholar]
  • 11.Lipton HL, Dal Canto M. J. neural. Sci. 1979;42:391–405. doi: 10.1016/0022-510X(79)90172-2. [DOI] [PubMed] [Google Scholar]
  • 12.Panitch H, Petursson G, Georgsson G, Palsson P, Nathanson N. Lab. Invest. 1976;35:452–460. [PubMed] [Google Scholar]
  • 13.Tschannen R, Steck AJ, Schäfer R. Neurosci. Lett. 1979;15:295–300. doi: 10.1016/0304-3940(79)96129-9. [DOI] [PubMed] [Google Scholar]
  • 14.Steck AJ, Tschannen R, Schäfer R. J. Neuroimmun. 1981;1:117–124. doi: 10.1016/0165-5728(81)90014-X. [DOI] [PubMed] [Google Scholar]
  • 15.Panitch SH, Swoveland P, Johnson KP. Neurology. 1979;29:548–549. [Google Scholar]
  • 16.Drzeniek R, Rott R. Int. Archs Allergy. 1969;36:146–152. [PubMed] [Google Scholar]
  • 17.Massanari RM, Paterson PY, Lipton HL. J. infect. Dis. 1979;139:297–303. doi: 10.1093/infdis/139.3.297. [DOI] [PubMed] [Google Scholar]
  • 18.Deibler GE, Martenson RE, Kies MW. Prep. Biochem. 1972;2:139–165. doi: 10.1080/00327487208061467. [DOI] [PubMed] [Google Scholar]

Articles from Nature are provided here courtesy of Nature Publishing Group

RESOURCES